HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Bon usage des médicaments utilisés dans les formes très actives de sclérose en plaques récurrente », ci-jointe, est adoptée.
See also
Évaluation des médicaments
08/10/2019
eNrdWE1z2jAQvfMrGA69ycYQCrSGTEuTlplkSkmYdnphhLWAqC05+gDSX18Zk4Z0TGkEOjQHM0aS366lt293HZ6vk7i8BCEpZ51K4FUrZWARJ5TNOpXR7SVqVc67pXCBl3hnWdOrekGtUo5iLGWnks16E8BMet+urz6AeR5EpVsqh3yygEg9WacVjb1PWM6vcZqtKYdLTkk5ATXnpFNJtdqMlkOphPGiu+Lih0xxBKG/HdmdXYzPdsdDPwP7B1QtQVxhNisEBWaFGWkhgKkeVjDj4r4QOhUkGNfarddBu2VlhMohSK5FBAOs5gPBl5QAKbQ1xbEEKyPTFbkBsYxBZUYKwf1FlEgrcLzA6yHc9Yudfmdme2qtUBUFzWajbq5aUG+0rUyJna0qpo95CT8d14MgqAWBD8wnENGM5YihWjVoI3M1fRL5EhJENApaSEKqIJkIyBeYwYjHMcwAEUAxRnOsFSDzwwVVm0GJmblJuVDmBmHCU5VZIEgzQFMazTerJmZIS5zhaJQAoRFODJ0sWTLIrMWO+EFl7ynXHdkRcHeQh4TKNMb33kKmtluFhdlpBcIokrsXyd7gVhiNjM2e/YHPdBz7z/R6tFUwRx5nAtnjmqk9QnY5tN2IHjfRsN5/onbaq9ZbLlKQp4P9yVlx3hnoSUwjW3E18qdBqtGwv19bX6YsvccSRsKdLn2ljPCVPL3e7fLLkfebk4gPlA2NhnU4fzdk3pN1L7TgKfhGCak8RuD6bMqPlTYTH8VQD9HxAgNjU47yCMewpyBFlnprIuKhfnYWc+7iOZ8oBP14cWtL1C8axP3N5m8hNCWd3xSzS0YuMpwJi0OO5wKSOV9ttNr1s1c4Sd8+dDody64mB/1rUzONxrVW86xVt2tptCgWvblSqXzj+6vVyptjmYelNxX/Q3o8LzyLU5yHyUWP9HLX/zmp0vKqNc9Djlyf5AXG8whlqySH6rhje5Pt89seqNCGEhqOOIs86ThLDf2L02ebx8bEmduDJ5rnzsymicCZrLgqKfWkOFMcld/MubJLYQTi89ToIDyPl6GffxTslkI/+yDYLf0C3hPDuw==
47ZXEybUqsSbVnbE
